AbCellera vs Adimab
AbCellera vs Adimab, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: AbCellera is on 41/100 and Adimab on 53/100.
Where each one leads
AbCellera
- domain rating: 56/100 against 39/100
Adimab
- our overall score: 53/100 against 41/100
- funding raised: $105M against $10.0M
At a glance
| Measure | AbCellera | Adimab |
|---|---|---|
| What it is | AI-powered platform for antibody discovery and development to create new medicines. | Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform. |
| Category | Biotech, Drug Discovery, Genomics, AI Drug Discovery | Biotech, Drug Discovery, Antibody Discovery, Therapeutic Antibodies |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2012 | 2007 |
| Headquarters | Vancouver, Canada | Lebanon, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | AbCellera | Adimab |
|---|---|---|
| Employees | Not published | 139 |
| Total funding | $10.0M | $105M |
| Latest round | Public Offering | Series B |
| LinkedIn followers | Not published | 8,423 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | AbCellera | Adimab |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 41/100 | 53/100 |
| Traction | 35/100 | 60/100 |
| Search visibility | 4/100 | 20/100 |
| Quality | 58/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (38/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 56/100 | 39/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | AbCellera | Adimab |
|---|---|---|
| Hosting | Not detected | AWS |
| CDN | Cloudflare | Not detected |
| CMS | Webflow | WordPress |
| Frameworks | Not detected | Jquery, Bootstrap |
| Analytics | Google Tag Manager | Google Tag Manager, Linkedin Insight |
| Support stack | Not detected | HubSpot |
AbCellera vs Adimab: common questions
Which is better, AbCellera or Adimab?
On our 0-100 score Adimab rates higher (53/100 against 41/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do AbCellera and Adimab compare on the numbers?
AbCellera leads on domain rating (56/100 against 39/100). Adimab leads on our overall score (53/100 against 41/100), funding raised ($105M against $10.0M).
Read the full AbCellera review and pricing or the Adimab review and pricing. You can also browse other AbCellera alternatives we track.